Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4266 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42 |
filingDate |
2002-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc219a9a5ce0d3e6cafcda521bfc23b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001c1c2175b1720c2e35c21abfb6726f |
publicationDate |
2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003035797-A1 |
titleOfInvention |
Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
abstract |
The present invention provides an anti-idiotypic monoclonal antibody which specifically induces an immune response against a glycosphingolipid. Additionally, this invention provides a method of producing the anti-idiotypic monoclonal antibody. Finally, this invention provides a composition of matter comprising an effective amount of a cytokine and a melanoma ganglioside-specific antibody attached to a carrier. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100968936-B1 |
priorityDate |
1992-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |